Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Talis Biomedical Corp (NQ: TLIS )

1.030 +0.030 (+2.99%)
Streaming Delayed Price Updated: 10:13 AM EDT, May 23, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 28,111
Open 1.030
Bid (Size) 1.000 (2)
Ask (Size) 1.030 (2)
Prev. Close 1.000
Today's Range 0.9900 - 1.050
52wk Range 0.9600 - 12.88
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Avalon Globocare (NASDAQ:AVCO) stock rose 14.8% to $0.54 during Tuesday's after-market session. The market value of their outstanding shares is at $47.8 million. 
Via Benzinga
NASDAQ:TLIS Long Term Investor Alert: Investigation of Potential Wrongdoing at Talis Biomedical Corporation
San Diego, CA -- (SBWIRE) -- 05/10/2022 -- Certain directors of Talis Biomedical Corporation are under investigation over potential breaches of fiduciary duties. 
Via SBWire

Performance

YTD
-75.42%
-75.42%
1 Month
-3.75%
-3.75%
3 Month
-49.51%
-49.51%
6 Month
-77.76%
-77.76%
1 Year
-89.96%
-89.96%

More News

Read More
Talis Biomedical's Return On Capital Employed Overview
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Manufacturing Bottlenecks Hit Launch Of Talis' FDA-Approved COVID-19 Test
Via Benzinga
Earnings Scheduled For May 10, 2022
Via Benzinga
80 Biggest Movers From Yesterday
Via Benzinga
Final Deadline Alert: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Earnings Scheduled For March 15, 2022
Via Benzinga
TLIS FINAL DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Talis Biomedical Corporation Investors with Losses to Secure Counsel Before Important March 8 Deadline in Securities Class Action TLIS
Via NewMediaWire
Deadline Tomorrow Alert: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Talis Biomedical Corporation (NASDAQ:TLIS) Investor Notice: Deadline in Lawsuit on March 8, 2021
Via SBWire
Deadline Tuesday Notice: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
TLIS FINAL DEADLINE TUESDAY: ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Talis Biomedical Corporation Investors with Losses to Secure Counsel Before Important March 8 Deadline in Securities Class Action - TLIS
Via NewMediaWire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Deadline Tuesday Alert: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Tuesday Deadline Reminder: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
7-Day Deadline Reminder: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
TLIS DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Talis Biomedical Corporation Investors with Losses Over $100K to Secure Counsel Before Important March 8 Deadline in Securities Class Action TLIS
Via NewMediaWire
FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Talis Biomedical Corporation Investors with Losses Over $100K to Secure Counsel Before Important March 8 Deadline in Securities Class Action TLIS
Via NewMediaWire
ROSEN, A TOP RANKED LAW FIRM, Encourages Talis Biomedical Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action TLIS
Via NewMediaWire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Investor Action Notice: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.